Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

0001055160-24-000005.txt

MFA Financial (NYSE:MFA-C)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more MFA Financial Charts.

MFA Financial (NYSE:MFA-C)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more MFA Financial Charts.

MFA Financial Inc News

Form 8-K - Current report
Thursday 22 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 8 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (4 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 22 February 2024 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 22 February 2024 (10 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 24 January 2024 (11 months ago) • Edgar (US Regulatory)

Form CERT - Certification by an exchange approving securities for listing
Friday 19 January 2024 (11 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 11 January 2024 (11 months ago) • Edgar (US Regulatory)

Form 8-A12B - Registration of securities [Section 12(b)]
Thursday 11 January 2024 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 10 January 2024 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 10 January 2024 (11 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 10 January 2024 (11 months ago) • Edgar (US Regulatory)

More MFA Financial Inc News Articles

Neuren Pharmaceuticals (PK)

Temple Bar Investment

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions